Al-Tuwaijri, H.M.; El-Rashedy, A.A.; Ansari, S.A.; Almomen, A.; Alkahtani, H.M.; Al-Abdullah, E.S.; Haiba, M.E.
Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines. Molecules 2025, 30, 3773.
https://doi.org/10.3390/molecules30183773
AMA Style
Al-Tuwaijri HM, El-Rashedy AA, Ansari SA, Almomen A, Alkahtani HM, Al-Abdullah ES, Haiba ME.
Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines. Molecules. 2025; 30(18):3773.
https://doi.org/10.3390/molecules30183773
Chicago/Turabian Style
Al-Tuwaijri, Hanaa M., Ahmed A. El-Rashedy, Siddique Akber Ansari, Aliyah Almomen, Hamad M. Alkahtani, Ebtehal S. Al-Abdullah, and Mogedda E. Haiba.
2025. "Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines" Molecules 30, no. 18: 3773.
https://doi.org/10.3390/molecules30183773
APA Style
Al-Tuwaijri, H. M., El-Rashedy, A. A., Ansari, S. A., Almomen, A., Alkahtani, H. M., Al-Abdullah, E. S., & Haiba, M. E.
(2025). Indazol-Pyrimidine Hybrids: Design, Synthesis, and Antiproliferative Activity Against Human Cancer Cell Lines. Molecules, 30(18), 3773.
https://doi.org/10.3390/molecules30183773